Dow Up 1.31% Nasdaq Up 2.40%

Chimerix, Inc. (CMRX)

-NasdaqGM
30.24 Oct 21, 4:00PM EDT
Prev Close:30.24
Open:N/A
Bid:30.70 x 200
Ask:31.42 x 100
1y Target Est:39.71
Beta:1.017
Earnings Date:Nov 12 - Nov 17 (Est.)
Day's Range:N/A - N/A
52wk Range:12.96 - 36.75
Volume:0
Avg Vol (3m):1,002,500
Market Cap:1.08B
P/E (ttm):N/A
EPS (ttm):-1.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
CMRX 0.00%1.08B
GNBT18.06M
GILD161.25B
SIGA78.12M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):309.06
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.68
Quarterly EPS Est (Sep-14) :-0.41
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel, oral antivirals to address unmet medical needs in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback